Author Details

Noweta, Marcin, Poland

  • Vol 8, No 3 (2022) - ORIGINAL ARTICLES
    Analysis of access to treatment of patients with moderate and severe psoriasis within nationally founded treatment program “Treatment of moderate and severe form of plaque psoriasis (ICD-10 L 40.0)” in 2016–2021
    Abstract
  • Vol 9, No 1 (2023) - ORIGINAL ARTICLES
    Analysis of access to treatment of patients with psoriatic arthritis within nationally founded treatment program B.35 “Treatment of active Psoriatic arthritis (PsA) (ICD-10 L 40.5, M 07.1, M 07.2, M 07.3)” in 2016–2021
    Abstract
  • Vol 9, No 2 (2023) - ORIGINAL ARTICLES
    Efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis: a real-life retrospective study
    Abstract

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl